SlideShare a Scribd company logo
1 of 17
Download to read offline
Continental Europe
From a disparate to a
coherent portfolio of
activities

Steven Braekeveldt
CEO Ageas Continental
Europe

INVESTOR DAY 2012
From a disparate to a coherent portfolio of activities
Continental Europe in 2009 vs. today

Life

Life

Non-Life
Mixed

Non-Life
Mixed

(6%) Non-Life (EUR 0.1 bn)
Non-Life (EUR 0.5 bn)

Inflows* 6M 2009: EUR 1.7 bn
(94%) Life (EUR 1.6 bn)

Inflows* 6M 2012: EUR 2.1 bn
(75%) Life (EUR 1.6 bn)

 Portfolio of entities with small market positions

 Focus on core entities

 Mix of wholly-owned subsidiaries, greenfield,
partnerships,…

 Clear focus on partnerships

 Dominance Life savings (35%Life inflow)

 Strategic shift towards Protection
(Non-Life and Life risk)

 Portfolio of entities (geographic approach)

 Integrated approach: tight internal cooperation

 Transformation from a Sell & Hold strategy towards a Buy & Build strategy
 Focus switch from portfolio restructuring to supporting growth of local operating companies
*incl. non-consolidated partnerships at 100%

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

1
Continental Europe today
Zoom in on Non-Life activities
GWP 6M 2012
Luxembourg (Life)

France (Life)

Portugal (24%)
Turkey (56%)

EUR 537 mio
Portugal (Life + Non-Life)
Ownership: 51%
#2 overall insurer (Life + NL)
Inflows 2011: EUR 1,308 mio
- Life: EUR 1,071 mio
- Non-Life: EUR 237 mio

Turkey (Non-Life)
Ownership: 36%
#3 Non-Life insurer
GWP 2011: EUR 177 mio*

Italy (20%)

* Consolidated amount – GWP 2011:
TRY 1,137 mio (EUR 486 mio)

Italy (Non-Life)
Ownership: 25%
#3 Non-Life insurer
GWP 2011: EUR 216 mio
Investor Day 24&25 September 2012 - Andaz Liverpool Street London

2
Continental Europe today
Zoom in on Non-Life activities
Portugal


JV with MBCP (N°2 bank in Portugal - 880 branches - 3 million clients)



Partnership in bancassurance



25 years exclusive distribution agreement with MBCP

Italy


Strategic partnership in Non-Life bancassurance with BNP Paribas Cardif and UBI Banca
(N°4 bank in Italy – 2,000 branches – 4 million clients)



10 years exclusive distribution agreement with UBI Banca

Turkey


Acquisition of a 36% stake in Aksigorta, the N°4 Non-Life insurer at that time (N°3 today)



Distribution: combination of agency network (1,600 agents) with bancassurance through
Akbank (N°4 bank in Turkey - 900 branches - 8 millions clients)



15 years exclusive distribution agreement with Akbank

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

3
Insurance environment
Non-Life Insurance: present challenges

 Economic slowdown


 Better informed and

in Europe (esp.
Portugal & Italy)
Volatile capital
markets






Economic
environment Customers
 Lower credit



production by banks
impacts associated
sales
Increasing diversity
and competition
between distribution
channels(affinities,
retailers,
aggregators…)

Distribution

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

Regulation

demanding
Hybrid customers
More price focus and more
selective
Raising claims frequency
and fraud

 Increasing new
regulations (Solvency II,
Gender Ban, Worker
Compensation Act in
Portugal, Bersani and
Monti laws in Italy, Turkish
rules re. calculation of
reserves, …)

4
Insurance environment
Non-Life Insurance: opportunities

 Young and dynamic




population in Turkey
Decline in investment
income drives focus
on underwriting
performance
Aging population in
Europe creates
potential in Health

 New technologies’


Economic
environment Customers
Distribution

 Banks increased focus


on fee and
commission income
Opportunities to
further grow nonassociated sales in the
bank channels

Investor Day 24&25 September 2012 - Andaz Liverpool Street London



availability enable new
approaches:
Personalized, pro-active
and real-time
communication via social
media
Tailor-made Motor
products via Telematics

Regulation
 Turkey: introduction of a
compulsory insurance
disaster policy

5
Strategy for Non-Life

Organic growth

External growth

 Focus on sustainable profitability
 3 entities with specific skills, know-how and stage of
development
Integrated approach with tight internal cooperation
Products
• Portugal: New
P&C products
• Italy & Turkey:
Increase nonMotor contribution

Operational Excellence
• Portugal: Medis
• Italy & Turkey:
- Pricing,
- Segmentation,
- Reserves methodology,
- Claim process,
- Fraud prevention

Distribution
• Portugal: New
P&C products
• Italy & Turkey:
Increase nonMotor
contribution

 Add-on acquisitions in
existing markets to reinforce
our position

 New markets
− Preferably Emerging
markets
− Partnership model
− Leading market position
− Meaningful contribution
− ROE > 11%

Pool of people and technical skills available
Investor Day 24&25 September 2012 - Andaz Liverpool Street London

6
Road map prioritizing our actions for external growth
 Process and value chain optimized for new partnerships
 Allows immediate roll-out of best practices and transfer of knowledge
 Three distinct phases with clear priorities :
Quick wins
(0-6 months)
 Improving the financials :
•Active management of
Investment portfolio
•Balance sheet analysis
 Integration in Knowledge
Sharing Platform (Fraud,
Claims, Cross selling,
Bancassuance, Agents,…)
 Governance and reporting
standards

Improving business case
(6-18 months)
 Portfolio optimization
• Diversification of product mix
• Improving existing products
(if relevant)
 Distribution optimization
• Bancassurance
• Agents
 Technical performance:
• Underwriting
• Pricing
• Segmentation
• Claims
• Fraud
• Reinsurance (insourcing vs.
outsourcing of risks)

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

LT development
Projects(>18months)
 Co-development of new,
complementary products
 Introduction of additional
distribution channels
 IT systems

 Advanced Risk Management
 Advanced Capital Management
(e.g. Solvency II)

7
Ensure sustainable profitability
Portugal (1/3)
GWP breakdown – Evolution 2009-2011 (in EUR mio)

GDP growth in 2011*) and contracting
insurance market (-0.9% in 2011), Mbcp
Ageas increased its Non-Life premiums by 2%

CAGR: +2.9%
214

231

237

31%

30%

31%

P&C business

 Health dominates, representing 59% of the

31 %

58%

Health
60%

11 %

2009

total Non-Life portfolio and a market share of
25% (Medis business model)

Motor

 In total Non-Life, Mbcp Ageas remains a

59%
60 %

58 %

11%

 In a context of economic recession (-1.6%

10%

10 %

2010

10%

10 %

modest player (market share of 5.5%)

2011

Evolution of Mbcp Ageas compared to the market

 A business transformation plan is set up to

)

(current year vs. prior year, GWP in EUR mio)
Mbcp Ageas

increase P&C and Motor contributions
Portuguese Market

GWP
Market share
GWP
Evolution
June 2012
June 2012* June 2012

Evolution

Total Non-Life

125.9

1.0%

5.6%

2,058.7

(3.90)%

Health

78.7

(1.8)%

24.7%

315.9

0.00%

Personal Accidents
Worker
Compensation
Fire

7.5

7.4%

9.3%

65.2

(4.30)%

3.8

25.7%

1.2%

295.5

(10.30)%

22.4

4.5%

6.9%

400.3

9.9

(4.1)%

1.3%

822.7

(4.60)%

Other

3.6

30.0%

2.3%

159.1

(i) ensuring profitability drivers defending the
product margin while balancing the portfolio
(ii) growing in stand-alone sales
(iii) operating simple and efficient processes

(1.50)%

Motor

 Strategic priorities aim at :

(0.80)%

Note: market share are calculated over the rolling last 12 months
Investor Day 24&25 September 2012 - Andaz Liverpool Street London

*Source: World bank
8
Ensure sustainable profitability
Portugal (2/3)
Evolution of Non-Life operating margin, 6M 2011-2012
In EUR mio – before costs allocation
H1 2011: Total Non-Life operating margin = EUR 32 mio
13.2 13.1

H1 2012 : Total Non-Life operating margin = EUR 35 mio
9.1 8.8

7.5

2011: Measures taken to improve technical

5.5

5.1

3.7

margins (e.g. Non-Life Claims platform)

Strong MS in Health and PA but still modest
Health

Motor

Fire

position in the Non-Life market (5.5%)

Other P&C

17.1%

47%

33.3%

nc

Op margin/GWP

24.7%

1.3%

6.9%

nc

Market share
(6M 2012)

Evolution of GWP per business line, 6M 2009-2012
In EUR mio
CAGR 2009-2012:
+5.8%

Evolution of Net profit in Non-Life, 6M 2011-2012
In EUR mio - 100% figure

6M 2009

76.8

6M 2010

64.9

CAGR: +20.3%

9.5

7.9

6M 2011
CAGR
2009-2012:
+5.3%

CAGR
2009-2012:
-3.4 %

19.2
12.1

6M 2012
22.4

10.9
3.6

Motor

WC

7.1

3.8

Fire

Health

7.5 4.1
1.8 1.6

PA

PPP

2.6

Other

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

6M 11

6M 12
9
Ensure sustainable profitability
Portugal (3/3) - Focus on Health
Health Insurance Market in Portugal:

 National Healthcare Service (NHS) is mainly public and Financing
is done through taxes

 Quality of logistics and speed to access health services are poor
 Private health insurance plans covers 10% of population
 Private provision of healthcare is focused on Hospitalization,
Specialist care and Pharmacy

 Based on the characteristics of Health
insurance Market in Portugal, Mbcp Ageas
launched its Health insurance platform in
1996: Medis.

 Innovating business model : the first to
introduce a managed care system in
Portugal providing high quality health care

 Operating model based on an integrated
system, a strong network of providers and
a multi-channel approach

Operating Model :

 2008: Medis grows twice the market and
 Customers are identified via their Medis card
 The system validates eligibility for medical act
 Through Medis site, Provider introduces the medical act code and
diagnosis

 The system informs the Provider of (i)the amount to be paid by the
customer and (ii) the amount to be paid to the Provider
 Medis pays directly to the Provider
7% Agents

20,5%
Distribution
Agreements

3% Direct Sales
69,5%
MBCP
Branches

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

registers the best satisfaction index for
customers and providers (97% customer
satisfaction in 2010 in Nielsen survey)

 2010: Medis represents EUR 136 mio
GWP

 2012: with a strong 25% market share,
Medis ranks 2nd on the Health insurance
market in Portugal (N° 1 = CGD with 33%)

 Healthcare is a business in which Ageas
has competences and expertise and in
which we believe we can grow
10
Ensure sustainable profitability
Italy (1/2)
GWP breakdown: Evolution 2009-2011
In EUR mio CAGR 2009-2011: +1,3%
210 mio

213 mio

15,5 %

10%

10,5%

216 mio

11%

35,5%

43,5%

Motor

38%

11%

30,5%

2009

36%

Accident &
Health

39%

36%

2010

 Strong performance in CPI Core
and Non-Motor

Others
Fire

14%
11,5%

 Focus on profitable growth (product
mix switch to more profitable LoB)

2011

Auto excluded South 2012 net production in #
439 2012
312
123
(129)
Jan

(376)
Feb
(376)

(322)

(78)

Mar
Apr
(429)

203
2011
(99)
May

Jun

 Better segmentation in Motor
 Reduction of Loss ratio on Motor
business (Over 3 points improvement
as lack of big claims in H1 2012)

(638)

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

11
Ensure sustainable profitability
Italy (2/2)

 Actions taken in 2011 to improve business

Health 2012 total net production in #

and redress profitability (a.o. banc
assurance product offer simplification)

 Portfolio being pruned, now set for growth:
 New products to increase non-Motor
contribution (BluFamily, new CPI, new
Household policies)
 Operations optimization:
− Claims management (rationalization of
claims settlement center)
− Implementation of a successful Fraud
Prevention Program (Black box)

1501

2012
1377

913

838

933

455

2011

830
479
Jan

393

352
Feb

Mar

Apr

476
290
May

Jun

 Introduction of a new Health product, Blu
Family, launched in Jan. 2012 and leading
to increased sales in Health

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

12
Leverage growth potential & enhance profitability
Turkey (1/2)

 Phase 1 “Quick wins” realized in 2011 (a.o.

Evolution of GWP per business line (Ytd)
In TRY mio

financials improved via active management of
the investment portfolio, workshops on
Knowledge Sharing)

706
607

15%

16%
9%
8%

11%
8%

Health
Gen. losses
Other

47%

2%
14%

6M 11

Motor

2%
17%

51%

Marine
Fire

 Now: Phase 2 “Improving business case”:
 Strategic shift towards non-Motor
 Agency channel profit and effectiveness

6M 12

optimization

Focus on profitable growth – Market GWP Analysis
June 2012
Aksigorta

Market

 Underwriting / Pricing / Reserves Methodologies
 Claims process reengineering (Claim

Management, Fraud prevention, IT systems, …)

Top 10
55%

 Bancassurance

45%

43%
38%
31%
18%
19%
16%

13%
10%

21%

15% 15%
14%

22%
23%
22%
22%

65%

59%

8%
3% 2%

Total
GWP

Fire

Marine

Motor

Other

General
losses

Health

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

13
Leverage growth potential & enhance profitability
Turkey (2/2)
Evolution of GWP per distribution channel (Ytd)
In %

Direct sales (13%)

108

Brokers (9%)

Banks (13%)

Evolution of combined ratio

EUR 275
mio

Agencies (65%)

107 Market (Non-Life)

106.5

106

101.6

6M 11
99

Direct sales (11%)

Aksigorta
Brokers (13%)
EUR 302
mio

Agencies (59%)
2009

Banks (14%)

2010

2011

6M 12

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

14
Conclusion: Robust Performance
of Ageas Continental Europe Non-Life activities
Combined ratio CEU** 2009 – 6M 12

Non-Life – evolution of GWP
In EUR mio
537
Other

83
101.3%

Fire

87

CAGR: +61% *
27.6%

62.4%

27
81

Accident &
Health

29.2%

29.3%

25.4%

27.5%

71.0%

66.4%

70.1%

67.3%

64.9%

61.0%

2010

2011

3M 11

6M 11

3M 12

6M 12

170
2009

6M 09

30.3%

88.5%

197

128
10
12

96.6%
90.3%

30.3%

Motor

99.3%

96.7%

90.0%

6M 12

* integration Turkey as of end 2011

claims ratio

expense ratio

** excluding Turkey

 Blueprint set up and ready for deployment Vision 2015
 Pool of people with technical skills available for execution

Investor Day 24&25 September 2012 - Andaz Liverpool Street London

15
Disclaimer
Certain of the statements contained herein are statements of
future expectations and other forward-looking statements
that are based on management's current views and
assumptions and involve known and unknown risks and
uncertainties that could cause actual results, performance or
events to differ materially from those expressed or implied in
such statements. Future actual results, performance or
events may differ materially from those in such statements
due to, without limitation, (i) general economic conditions,
including in particular economic conditions in Ageas’s core
markets, (ii) performance of financial markets, (iii) the
frequency and severity of insured loss events, (iv) mortality
and morbidity levels and trends, (v) persistency levels, (vi)
interest rate levels, (vii) currency exchange rates, (viii)
increasing levels of competition, (ix) changes in laws and
regulations, including monetary convergence and the
Economic and Monetary Union, (x) changes in the policies of
central banks and/or foreign governments and (xi) general
competitive factors, in each case on a global, regional and/or
national basis. In addition, the financial information
contained in this presentation, including the pro forma
information contained herein, is unaudited and is provided
for illustrative purposes only. It does not purport to be
indicative of what the actual results of operations or financial
condition of Ageas and its subsidiaries would have been had
these events occurred or transactions been consummated
on or as of the dates indicated, nor does it purport to be
indicative of the results of operations or financial condition
that may be achieved in the future.
Investor Day 24&25 September 2012 - Andaz Liverpool Street London

16

More Related Content

What's hot

Investor Day 2015 - A smooth transition to Solvency II
Investor Day 2015 - A smooth transition to Solvency IIInvestor Day 2015 - A smooth transition to Solvency II
Investor Day 2015 - A smooth transition to Solvency IIAgeas
 
Investor Day 2011 - Asian Key Financials
Investor Day 2011 - Asian Key FinancialsInvestor Day 2011 - Asian Key Financials
Investor Day 2011 - Asian Key FinancialsAgeas
 
Merrill Lynch Banking & Insurance Conference 2015
Merrill Lynch Banking & Insurance Conference 2015Merrill Lynch Banking & Insurance Conference 2015
Merrill Lynch Banking & Insurance Conference 2015Ageas
 
Investor Day 2012 - Closing Remarks Ageas UK
Investor Day 2012 - Closing Remarks Ageas UKInvestor Day 2012 - Closing Remarks Ageas UK
Investor Day 2012 - Closing Remarks Ageas UKAgeas
 
Investor Day 2009 - Regional business presentation
Investor Day 2009 - Regional business presentation Investor Day 2009 - Regional business presentation
Investor Day 2009 - Regional business presentation Ageas
 
9M 2015 Results - Periodical Financials Information
9M 2015 Results - Periodical Financials Information9M 2015 Results - Periodical Financials Information
9M 2015 Results - Periodical Financials InformationAgeas
 
Investor Day 2012 - Asian Non Life Markets
Investor Day 2012 - Asian Non Life MarketsInvestor Day 2012 - Asian Non Life Markets
Investor Day 2012 - Asian Non Life MarketsAgeas
 
Presentation 3M 2016 results
Presentation 3M 2016 resultsPresentation 3M 2016 results
Presentation 3M 2016 resultsAgeas
 
Investor Day 2012 - Distribution and Customers
Investor Day 2012 - Distribution and Customers Investor Day 2012 - Distribution and Customers
Investor Day 2012 - Distribution and Customers Ageas
 
Investor Day 2009 - Regional business presentation Belgium
Investor Day 2009 - Regional business presentation BelgiumInvestor Day 2009 - Regional business presentation Belgium
Investor Day 2009 - Regional business presentation BelgiumAgeas
 
Ageas Corporate Presentation
Ageas Corporate PresentationAgeas Corporate Presentation
Ageas Corporate PresentationAgeas
 
Ageas Full Year 2015 Results (presentation)
Ageas Full Year 2015 Results (presentation)Ageas Full Year 2015 Results (presentation)
Ageas Full Year 2015 Results (presentation)Ageas
 
Investor Day 2009 - Deputy CEO presentation
Investor Day 2009 - Deputy CEO presentationInvestor Day 2009 - Deputy CEO presentation
Investor Day 2009 - Deputy CEO presentationAgeas
 
2015 AGM Presentation
2015 AGM Presentation2015 AGM Presentation
2015 AGM PresentationAegon
 
Aegon UK Strategy Update - September 2, 2014
Aegon UK Strategy Update - September 2, 2014Aegon UK Strategy Update - September 2, 2014
Aegon UK Strategy Update - September 2, 2014Aegon
 
Investor Day 2011 Bart De Smet
Investor Day 2011 Bart De SmetInvestor Day 2011 Bart De Smet
Investor Day 2011 Bart De SmetAgeas
 
2016 Annual General Meeting of Shareholders Aegon N.V.
2016 Annual General Meeting of Shareholders Aegon N.V.2016 Annual General Meeting of Shareholders Aegon N.V.
2016 Annual General Meeting of Shareholders Aegon N.V.Aegon
 
Aegon Americas Strategy Update - September 8, 2014
Aegon Americas Strategy Update - September 8, 2014Aegon Americas Strategy Update - September 8, 2014
Aegon Americas Strategy Update - September 8, 2014Aegon
 
Aegon Q2 2014 Results Presentation
Aegon Q2 2014 Results PresentationAegon Q2 2014 Results Presentation
Aegon Q2 2014 Results PresentationAegon
 
Aegon Q1 2015 Results Presentation
Aegon Q1 2015 Results PresentationAegon Q1 2015 Results Presentation
Aegon Q1 2015 Results PresentationAegon
 

What's hot (20)

Investor Day 2015 - A smooth transition to Solvency II
Investor Day 2015 - A smooth transition to Solvency IIInvestor Day 2015 - A smooth transition to Solvency II
Investor Day 2015 - A smooth transition to Solvency II
 
Investor Day 2011 - Asian Key Financials
Investor Day 2011 - Asian Key FinancialsInvestor Day 2011 - Asian Key Financials
Investor Day 2011 - Asian Key Financials
 
Merrill Lynch Banking & Insurance Conference 2015
Merrill Lynch Banking & Insurance Conference 2015Merrill Lynch Banking & Insurance Conference 2015
Merrill Lynch Banking & Insurance Conference 2015
 
Investor Day 2012 - Closing Remarks Ageas UK
Investor Day 2012 - Closing Remarks Ageas UKInvestor Day 2012 - Closing Remarks Ageas UK
Investor Day 2012 - Closing Remarks Ageas UK
 
Investor Day 2009 - Regional business presentation
Investor Day 2009 - Regional business presentation Investor Day 2009 - Regional business presentation
Investor Day 2009 - Regional business presentation
 
9M 2015 Results - Periodical Financials Information
9M 2015 Results - Periodical Financials Information9M 2015 Results - Periodical Financials Information
9M 2015 Results - Periodical Financials Information
 
Investor Day 2012 - Asian Non Life Markets
Investor Day 2012 - Asian Non Life MarketsInvestor Day 2012 - Asian Non Life Markets
Investor Day 2012 - Asian Non Life Markets
 
Presentation 3M 2016 results
Presentation 3M 2016 resultsPresentation 3M 2016 results
Presentation 3M 2016 results
 
Investor Day 2012 - Distribution and Customers
Investor Day 2012 - Distribution and Customers Investor Day 2012 - Distribution and Customers
Investor Day 2012 - Distribution and Customers
 
Investor Day 2009 - Regional business presentation Belgium
Investor Day 2009 - Regional business presentation BelgiumInvestor Day 2009 - Regional business presentation Belgium
Investor Day 2009 - Regional business presentation Belgium
 
Ageas Corporate Presentation
Ageas Corporate PresentationAgeas Corporate Presentation
Ageas Corporate Presentation
 
Ageas Full Year 2015 Results (presentation)
Ageas Full Year 2015 Results (presentation)Ageas Full Year 2015 Results (presentation)
Ageas Full Year 2015 Results (presentation)
 
Investor Day 2009 - Deputy CEO presentation
Investor Day 2009 - Deputy CEO presentationInvestor Day 2009 - Deputy CEO presentation
Investor Day 2009 - Deputy CEO presentation
 
2015 AGM Presentation
2015 AGM Presentation2015 AGM Presentation
2015 AGM Presentation
 
Aegon UK Strategy Update - September 2, 2014
Aegon UK Strategy Update - September 2, 2014Aegon UK Strategy Update - September 2, 2014
Aegon UK Strategy Update - September 2, 2014
 
Investor Day 2011 Bart De Smet
Investor Day 2011 Bart De SmetInvestor Day 2011 Bart De Smet
Investor Day 2011 Bart De Smet
 
2016 Annual General Meeting of Shareholders Aegon N.V.
2016 Annual General Meeting of Shareholders Aegon N.V.2016 Annual General Meeting of Shareholders Aegon N.V.
2016 Annual General Meeting of Shareholders Aegon N.V.
 
Aegon Americas Strategy Update - September 8, 2014
Aegon Americas Strategy Update - September 8, 2014Aegon Americas Strategy Update - September 8, 2014
Aegon Americas Strategy Update - September 8, 2014
 
Aegon Q2 2014 Results Presentation
Aegon Q2 2014 Results PresentationAegon Q2 2014 Results Presentation
Aegon Q2 2014 Results Presentation
 
Aegon Q1 2015 Results Presentation
Aegon Q1 2015 Results PresentationAegon Q1 2015 Results Presentation
Aegon Q1 2015 Results Presentation
 

Similar to Investor Day 2012 - Continental Europe

Citi European Insurance Conference
Citi European Insurance ConferenceCiti European Insurance Conference
Citi European Insurance ConferenceAegon
 
Aegon strategic update
Aegon strategic updateAegon strategic update
Aegon strategic updateAegon
 
Financial Report January-February 2016
Financial Report January-February 2016Financial Report January-February 2016
Financial Report January-February 2016BANCO SANTANDER
 
2015 Investor Day Presentation
2015 Investor Day Presentation2015 Investor Day Presentation
2015 Investor Day PresentationGenerali
 
Aegon Bank of America Merrill Lynch Financials Conference
Aegon Bank of America Merrill Lynch Financials ConferenceAegon Bank of America Merrill Lynch Financials Conference
Aegon Bank of America Merrill Lynch Financials ConferenceAegon
 
VFB 4 October 2014
VFB 4 October 2014 VFB 4 October 2014
VFB 4 October 2014 Ageas
 
2Q 2015 RESULTS Financial Report
2Q 2015 RESULTS Financial Report2Q 2015 RESULTS Financial Report
2Q 2015 RESULTS Financial ReportBANCO SANTANDER
 
Bpifrance 2017 activity report (English version)
Bpifrance 2017 activity report (English version)Bpifrance 2017 activity report (English version)
Bpifrance 2017 activity report (English version)Nicolas Dufourcq
 
Bpifrance's Activity Report 2017
Bpifrance's Activity Report 2017Bpifrance's Activity Report 2017
Bpifrance's Activity Report 2017Bpifrance
 
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse AG
 
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse AG
 
Pharma industry-executive-issue-38-2012
Pharma industry-executive-issue-38-2012Pharma industry-executive-issue-38-2012
Pharma industry-executive-issue-38-2012pfernandez
 
3M results 2010
3M results 2010 3M results 2010
3M results 2010 Ageas
 
3Q14 Financial Report Santander Bank
3Q14 Financial Report Santander Bank3Q14 Financial Report Santander Bank
3Q14 Financial Report Santander BankBANCO SANTANDER
 
GCF - Présentation Medical & Health - 1022.pdf
GCF - Présentation Medical & Health - 1022.pdfGCF - Présentation Medical & Health - 1022.pdf
GCF - Présentation Medical & Health - 1022.pdfLucas518833
 
GCF - Présentation Medical & Health - 1222.pdf
GCF - Présentation Medical & Health - 1222.pdfGCF - Présentation Medical & Health - 1222.pdf
GCF - Présentation Medical & Health - 1222.pdfHlnePEYRUSQUE
 
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)Can mutual insurance evolve into the Mainstream? (P&V, Belgium)
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)ICMIF Microinsurance
 
Sofie Emmertsen - Logica
Sofie Emmertsen - LogicaSofie Emmertsen - Logica
Sofie Emmertsen - LogicaSeismonaut
 

Similar to Investor Day 2012 - Continental Europe (20)

Citi European Insurance Conference
Citi European Insurance ConferenceCiti European Insurance Conference
Citi European Insurance Conference
 
Aegon strategic update
Aegon strategic updateAegon strategic update
Aegon strategic update
 
Financial Report January-February 2016
Financial Report January-February 2016Financial Report January-February 2016
Financial Report January-February 2016
 
2015 Investor Day Presentation
2015 Investor Day Presentation2015 Investor Day Presentation
2015 Investor Day Presentation
 
Aegon Bank of America Merrill Lynch Financials Conference
Aegon Bank of America Merrill Lynch Financials ConferenceAegon Bank of America Merrill Lynch Financials Conference
Aegon Bank of America Merrill Lynch Financials Conference
 
Piano Strategico di Generali 2015 - 2018
Piano Strategico di Generali 2015 - 2018Piano Strategico di Generali 2015 - 2018
Piano Strategico di Generali 2015 - 2018
 
Financial report 1Q2016
Financial report 1Q2016Financial report 1Q2016
Financial report 1Q2016
 
VFB 4 October 2014
VFB 4 October 2014 VFB 4 October 2014
VFB 4 October 2014
 
2Q 2015 RESULTS Financial Report
2Q 2015 RESULTS Financial Report2Q 2015 RESULTS Financial Report
2Q 2015 RESULTS Financial Report
 
Bpifrance 2017 activity report (English version)
Bpifrance 2017 activity report (English version)Bpifrance 2017 activity report (English version)
Bpifrance 2017 activity report (English version)
 
Bpifrance's Activity Report 2017
Bpifrance's Activity Report 2017Bpifrance's Activity Report 2017
Bpifrance's Activity Report 2017
 
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
 
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto FrancioniDeutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
Deutsche Börse Group Annual General Meeting 2014 Presentation CEO Reto Francioni
 
Pharma industry-executive-issue-38-2012
Pharma industry-executive-issue-38-2012Pharma industry-executive-issue-38-2012
Pharma industry-executive-issue-38-2012
 
3M results 2010
3M results 2010 3M results 2010
3M results 2010
 
3Q14 Financial Report Santander Bank
3Q14 Financial Report Santander Bank3Q14 Financial Report Santander Bank
3Q14 Financial Report Santander Bank
 
GCF - Présentation Medical & Health - 1022.pdf
GCF - Présentation Medical & Health - 1022.pdfGCF - Présentation Medical & Health - 1022.pdf
GCF - Présentation Medical & Health - 1022.pdf
 
GCF - Présentation Medical & Health - 1222.pdf
GCF - Présentation Medical & Health - 1222.pdfGCF - Présentation Medical & Health - 1222.pdf
GCF - Présentation Medical & Health - 1222.pdf
 
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)Can mutual insurance evolve into the Mainstream? (P&V, Belgium)
Can mutual insurance evolve into the Mainstream? (P&V, Belgium)
 
Sofie Emmertsen - Logica
Sofie Emmertsen - LogicaSofie Emmertsen - Logica
Sofie Emmertsen - Logica
 

More from Ageas

Ageas reports 9M 2017 result
Ageas reports 9M 2017 resultAgeas reports 9M 2017 result
Ageas reports 9M 2017 resultAgeas
 
Ageas reports 6M 2017 result
Ageas reports 6M 2017 resultAgeas reports 6M 2017 result
Ageas reports 6M 2017 resultAgeas
 
Ageas - Full Year 2016 Results
Ageas - Full Year 2016 ResultsAgeas - Full Year 2016 Results
Ageas - Full Year 2016 ResultsAgeas
 
Ageas - First Half Year 2016 Results
Ageas - First Half Year 2016 ResultsAgeas - First Half Year 2016 Results
Ageas - First Half Year 2016 ResultsAgeas
 
Bart De Smet @ VFB event (16th April 2016)
Bart De Smet @ VFB event (16th April 2016)Bart De Smet @ VFB event (16th April 2016)
Bart De Smet @ VFB event (16th April 2016)Ageas
 
Settlement on Fortis events (2007-2008)
Settlement on Fortis events (2007-2008)Settlement on Fortis events (2007-2008)
Settlement on Fortis events (2007-2008)Ageas
 
6M Results 2015 - Presentation Analysts and Institutional Investors
6M Results 2015 - Presentation Analysts and Institutional Investors6M Results 2015 - Presentation Analysts and Institutional Investors
6M Results 2015 - Presentation Analysts and Institutional InvestorsAgeas
 
3M results 2015 - Presentation Analysts and Institutional Investors
3M results 2015 - Presentation Analysts and Institutional Investors3M results 2015 - Presentation Analysts and Institutional Investors
3M results 2015 - Presentation Analysts and Institutional InvestorsAgeas
 
FY results 2014 - press presentation
FY results 2014 - press presentationFY results 2014 - press presentation
FY results 2014 - press presentationAgeas
 
FY results 2014
FY results 2014FY results 2014
FY results 2014Ageas
 
Acteursmondiale lecho 20141115
Acteursmondiale lecho 20141115Acteursmondiale lecho 20141115
Acteursmondiale lecho 20141115Ageas
 
Wereldspelers
Wereldspelers Wereldspelers
Wereldspelers Ageas
 
Finance Avenue 2014
Finance Avenue 2014Finance Avenue 2014
Finance Avenue 2014Ageas
 
9M results 2014 - press presentation
9M results 2014 - press presentation 9M results 2014 - press presentation
9M results 2014 - press presentation Ageas
 
9M results 2014 - Presentation Analysts and institutional investors
9M results 2014 - Presentation Analysts and institutional investors9M results 2014 - Presentation Analysts and institutional investors
9M results 2014 - Presentation Analysts and institutional investorsAgeas
 
Regulatory impact on banks and insurers investments
Regulatory impact on banks and insurers investmentsRegulatory impact on banks and insurers investments
Regulatory impact on banks and insurers investmentsAgeas
 
6M results 2014 Press Conference
6M results 2014 Press Conference 6M results 2014 Press Conference
6M results 2014 Press Conference Ageas
 
6M results 2014
6M results 20146M results 2014
6M results 2014Ageas
 
Ageas Club 26 06 2014
Ageas Club 26 06 2014Ageas Club 26 06 2014
Ageas Club 26 06 2014Ageas
 
3M results 2014 - Press
3M results 2014 - Press3M results 2014 - Press
3M results 2014 - PressAgeas
 

More from Ageas (20)

Ageas reports 9M 2017 result
Ageas reports 9M 2017 resultAgeas reports 9M 2017 result
Ageas reports 9M 2017 result
 
Ageas reports 6M 2017 result
Ageas reports 6M 2017 resultAgeas reports 6M 2017 result
Ageas reports 6M 2017 result
 
Ageas - Full Year 2016 Results
Ageas - Full Year 2016 ResultsAgeas - Full Year 2016 Results
Ageas - Full Year 2016 Results
 
Ageas - First Half Year 2016 Results
Ageas - First Half Year 2016 ResultsAgeas - First Half Year 2016 Results
Ageas - First Half Year 2016 Results
 
Bart De Smet @ VFB event (16th April 2016)
Bart De Smet @ VFB event (16th April 2016)Bart De Smet @ VFB event (16th April 2016)
Bart De Smet @ VFB event (16th April 2016)
 
Settlement on Fortis events (2007-2008)
Settlement on Fortis events (2007-2008)Settlement on Fortis events (2007-2008)
Settlement on Fortis events (2007-2008)
 
6M Results 2015 - Presentation Analysts and Institutional Investors
6M Results 2015 - Presentation Analysts and Institutional Investors6M Results 2015 - Presentation Analysts and Institutional Investors
6M Results 2015 - Presentation Analysts and Institutional Investors
 
3M results 2015 - Presentation Analysts and Institutional Investors
3M results 2015 - Presentation Analysts and Institutional Investors3M results 2015 - Presentation Analysts and Institutional Investors
3M results 2015 - Presentation Analysts and Institutional Investors
 
FY results 2014 - press presentation
FY results 2014 - press presentationFY results 2014 - press presentation
FY results 2014 - press presentation
 
FY results 2014
FY results 2014FY results 2014
FY results 2014
 
Acteursmondiale lecho 20141115
Acteursmondiale lecho 20141115Acteursmondiale lecho 20141115
Acteursmondiale lecho 20141115
 
Wereldspelers
Wereldspelers Wereldspelers
Wereldspelers
 
Finance Avenue 2014
Finance Avenue 2014Finance Avenue 2014
Finance Avenue 2014
 
9M results 2014 - press presentation
9M results 2014 - press presentation 9M results 2014 - press presentation
9M results 2014 - press presentation
 
9M results 2014 - Presentation Analysts and institutional investors
9M results 2014 - Presentation Analysts and institutional investors9M results 2014 - Presentation Analysts and institutional investors
9M results 2014 - Presentation Analysts and institutional investors
 
Regulatory impact on banks and insurers investments
Regulatory impact on banks and insurers investmentsRegulatory impact on banks and insurers investments
Regulatory impact on banks and insurers investments
 
6M results 2014 Press Conference
6M results 2014 Press Conference 6M results 2014 Press Conference
6M results 2014 Press Conference
 
6M results 2014
6M results 20146M results 2014
6M results 2014
 
Ageas Club 26 06 2014
Ageas Club 26 06 2014Ageas Club 26 06 2014
Ageas Club 26 06 2014
 
3M results 2014 - Press
3M results 2014 - Press3M results 2014 - Press
3M results 2014 - Press
 

Recently uploaded

Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024CollectiveMining1
 
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd
 
Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Probe Gold
 
Falcon Invoice Discounting unlock your cash flow potential
Falcon Invoice Discounting unlock your cash flow potentialFalcon Invoice Discounting unlock your cash flow potential
Falcon Invoice Discounting unlock your cash flow potentialFalcon Invoice Discounting
 
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024CollectiveMining1
 
Mandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalayResources
 

Recently uploaded (7)

Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024Collective Mining | Corporate Presentation | April 2024
Collective Mining | Corporate Presentation | April 2024
 
Korea District Heating Corporation 071320 Algorithm Investment Report
Korea District Heating Corporation 071320 Algorithm Investment ReportKorea District Heating Corporation 071320 Algorithm Investment Report
Korea District Heating Corporation 071320 Algorithm Investment Report
 
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, April 10, 2024
 
Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024Q1 Probe Gold Quarterly Update- April 2024
Q1 Probe Gold Quarterly Update- April 2024
 
Falcon Invoice Discounting unlock your cash flow potential
Falcon Invoice Discounting unlock your cash flow potentialFalcon Invoice Discounting unlock your cash flow potential
Falcon Invoice Discounting unlock your cash flow potential
 
Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024Collective Mining | Corporate Presentation - April 2024
Collective Mining | Corporate Presentation - April 2024
 
Mandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR PresentationMandalay Resources 2024 April IR Presentation
Mandalay Resources 2024 April IR Presentation
 

Investor Day 2012 - Continental Europe

  • 1. Continental Europe From a disparate to a coherent portfolio of activities Steven Braekeveldt CEO Ageas Continental Europe INVESTOR DAY 2012
  • 2. From a disparate to a coherent portfolio of activities Continental Europe in 2009 vs. today Life Life Non-Life Mixed Non-Life Mixed (6%) Non-Life (EUR 0.1 bn) Non-Life (EUR 0.5 bn) Inflows* 6M 2009: EUR 1.7 bn (94%) Life (EUR 1.6 bn) Inflows* 6M 2012: EUR 2.1 bn (75%) Life (EUR 1.6 bn)  Portfolio of entities with small market positions  Focus on core entities  Mix of wholly-owned subsidiaries, greenfield, partnerships,…  Clear focus on partnerships  Dominance Life savings (35%Life inflow)  Strategic shift towards Protection (Non-Life and Life risk)  Portfolio of entities (geographic approach)  Integrated approach: tight internal cooperation  Transformation from a Sell & Hold strategy towards a Buy & Build strategy  Focus switch from portfolio restructuring to supporting growth of local operating companies *incl. non-consolidated partnerships at 100% Investor Day 24&25 September 2012 - Andaz Liverpool Street London 1
  • 3. Continental Europe today Zoom in on Non-Life activities GWP 6M 2012 Luxembourg (Life) France (Life) Portugal (24%) Turkey (56%) EUR 537 mio Portugal (Life + Non-Life) Ownership: 51% #2 overall insurer (Life + NL) Inflows 2011: EUR 1,308 mio - Life: EUR 1,071 mio - Non-Life: EUR 237 mio Turkey (Non-Life) Ownership: 36% #3 Non-Life insurer GWP 2011: EUR 177 mio* Italy (20%) * Consolidated amount – GWP 2011: TRY 1,137 mio (EUR 486 mio) Italy (Non-Life) Ownership: 25% #3 Non-Life insurer GWP 2011: EUR 216 mio Investor Day 24&25 September 2012 - Andaz Liverpool Street London 2
  • 4. Continental Europe today Zoom in on Non-Life activities Portugal  JV with MBCP (N°2 bank in Portugal - 880 branches - 3 million clients)  Partnership in bancassurance  25 years exclusive distribution agreement with MBCP Italy  Strategic partnership in Non-Life bancassurance with BNP Paribas Cardif and UBI Banca (N°4 bank in Italy – 2,000 branches – 4 million clients)  10 years exclusive distribution agreement with UBI Banca Turkey  Acquisition of a 36% stake in Aksigorta, the N°4 Non-Life insurer at that time (N°3 today)  Distribution: combination of agency network (1,600 agents) with bancassurance through Akbank (N°4 bank in Turkey - 900 branches - 8 millions clients)  15 years exclusive distribution agreement with Akbank Investor Day 24&25 September 2012 - Andaz Liverpool Street London 3
  • 5. Insurance environment Non-Life Insurance: present challenges  Economic slowdown   Better informed and in Europe (esp. Portugal & Italy) Volatile capital markets    Economic environment Customers  Lower credit  production by banks impacts associated sales Increasing diversity and competition between distribution channels(affinities, retailers, aggregators…) Distribution Investor Day 24&25 September 2012 - Andaz Liverpool Street London Regulation demanding Hybrid customers More price focus and more selective Raising claims frequency and fraud  Increasing new regulations (Solvency II, Gender Ban, Worker Compensation Act in Portugal, Bersani and Monti laws in Italy, Turkish rules re. calculation of reserves, …) 4
  • 6. Insurance environment Non-Life Insurance: opportunities  Young and dynamic   population in Turkey Decline in investment income drives focus on underwriting performance Aging population in Europe creates potential in Health  New technologies’  Economic environment Customers Distribution  Banks increased focus  on fee and commission income Opportunities to further grow nonassociated sales in the bank channels Investor Day 24&25 September 2012 - Andaz Liverpool Street London  availability enable new approaches: Personalized, pro-active and real-time communication via social media Tailor-made Motor products via Telematics Regulation  Turkey: introduction of a compulsory insurance disaster policy 5
  • 7. Strategy for Non-Life Organic growth External growth  Focus on sustainable profitability  3 entities with specific skills, know-how and stage of development Integrated approach with tight internal cooperation Products • Portugal: New P&C products • Italy & Turkey: Increase nonMotor contribution Operational Excellence • Portugal: Medis • Italy & Turkey: - Pricing, - Segmentation, - Reserves methodology, - Claim process, - Fraud prevention Distribution • Portugal: New P&C products • Italy & Turkey: Increase nonMotor contribution  Add-on acquisitions in existing markets to reinforce our position  New markets − Preferably Emerging markets − Partnership model − Leading market position − Meaningful contribution − ROE > 11% Pool of people and technical skills available Investor Day 24&25 September 2012 - Andaz Liverpool Street London 6
  • 8. Road map prioritizing our actions for external growth  Process and value chain optimized for new partnerships  Allows immediate roll-out of best practices and transfer of knowledge  Three distinct phases with clear priorities : Quick wins (0-6 months)  Improving the financials : •Active management of Investment portfolio •Balance sheet analysis  Integration in Knowledge Sharing Platform (Fraud, Claims, Cross selling, Bancassuance, Agents,…)  Governance and reporting standards Improving business case (6-18 months)  Portfolio optimization • Diversification of product mix • Improving existing products (if relevant)  Distribution optimization • Bancassurance • Agents  Technical performance: • Underwriting • Pricing • Segmentation • Claims • Fraud • Reinsurance (insourcing vs. outsourcing of risks) Investor Day 24&25 September 2012 - Andaz Liverpool Street London LT development Projects(>18months)  Co-development of new, complementary products  Introduction of additional distribution channels  IT systems  Advanced Risk Management  Advanced Capital Management (e.g. Solvency II) 7
  • 9. Ensure sustainable profitability Portugal (1/3) GWP breakdown – Evolution 2009-2011 (in EUR mio) GDP growth in 2011*) and contracting insurance market (-0.9% in 2011), Mbcp Ageas increased its Non-Life premiums by 2% CAGR: +2.9% 214 231 237 31% 30% 31% P&C business  Health dominates, representing 59% of the 31 % 58% Health 60% 11 % 2009 total Non-Life portfolio and a market share of 25% (Medis business model) Motor  In total Non-Life, Mbcp Ageas remains a 59% 60 % 58 % 11%  In a context of economic recession (-1.6% 10% 10 % 2010 10% 10 % modest player (market share of 5.5%) 2011 Evolution of Mbcp Ageas compared to the market  A business transformation plan is set up to ) (current year vs. prior year, GWP in EUR mio) Mbcp Ageas increase P&C and Motor contributions Portuguese Market GWP Market share GWP Evolution June 2012 June 2012* June 2012 Evolution Total Non-Life 125.9 1.0% 5.6% 2,058.7 (3.90)% Health 78.7 (1.8)% 24.7% 315.9 0.00% Personal Accidents Worker Compensation Fire 7.5 7.4% 9.3% 65.2 (4.30)% 3.8 25.7% 1.2% 295.5 (10.30)% 22.4 4.5% 6.9% 400.3 9.9 (4.1)% 1.3% 822.7 (4.60)% Other 3.6 30.0% 2.3% 159.1 (i) ensuring profitability drivers defending the product margin while balancing the portfolio (ii) growing in stand-alone sales (iii) operating simple and efficient processes (1.50)% Motor  Strategic priorities aim at : (0.80)% Note: market share are calculated over the rolling last 12 months Investor Day 24&25 September 2012 - Andaz Liverpool Street London *Source: World bank 8
  • 10. Ensure sustainable profitability Portugal (2/3) Evolution of Non-Life operating margin, 6M 2011-2012 In EUR mio – before costs allocation H1 2011: Total Non-Life operating margin = EUR 32 mio 13.2 13.1 H1 2012 : Total Non-Life operating margin = EUR 35 mio 9.1 8.8 7.5 2011: Measures taken to improve technical 5.5 5.1 3.7 margins (e.g. Non-Life Claims platform) Strong MS in Health and PA but still modest Health Motor Fire position in the Non-Life market (5.5%) Other P&C 17.1% 47% 33.3% nc Op margin/GWP 24.7% 1.3% 6.9% nc Market share (6M 2012) Evolution of GWP per business line, 6M 2009-2012 In EUR mio CAGR 2009-2012: +5.8% Evolution of Net profit in Non-Life, 6M 2011-2012 In EUR mio - 100% figure 6M 2009 76.8 6M 2010 64.9 CAGR: +20.3% 9.5 7.9 6M 2011 CAGR 2009-2012: +5.3% CAGR 2009-2012: -3.4 % 19.2 12.1 6M 2012 22.4 10.9 3.6 Motor WC 7.1 3.8 Fire Health 7.5 4.1 1.8 1.6 PA PPP 2.6 Other Investor Day 24&25 September 2012 - Andaz Liverpool Street London 6M 11 6M 12 9
  • 11. Ensure sustainable profitability Portugal (3/3) - Focus on Health Health Insurance Market in Portugal:  National Healthcare Service (NHS) is mainly public and Financing is done through taxes  Quality of logistics and speed to access health services are poor  Private health insurance plans covers 10% of population  Private provision of healthcare is focused on Hospitalization, Specialist care and Pharmacy  Based on the characteristics of Health insurance Market in Portugal, Mbcp Ageas launched its Health insurance platform in 1996: Medis.  Innovating business model : the first to introduce a managed care system in Portugal providing high quality health care  Operating model based on an integrated system, a strong network of providers and a multi-channel approach Operating Model :  2008: Medis grows twice the market and  Customers are identified via their Medis card  The system validates eligibility for medical act  Through Medis site, Provider introduces the medical act code and diagnosis  The system informs the Provider of (i)the amount to be paid by the customer and (ii) the amount to be paid to the Provider  Medis pays directly to the Provider 7% Agents 20,5% Distribution Agreements 3% Direct Sales 69,5% MBCP Branches Investor Day 24&25 September 2012 - Andaz Liverpool Street London registers the best satisfaction index for customers and providers (97% customer satisfaction in 2010 in Nielsen survey)  2010: Medis represents EUR 136 mio GWP  2012: with a strong 25% market share, Medis ranks 2nd on the Health insurance market in Portugal (N° 1 = CGD with 33%)  Healthcare is a business in which Ageas has competences and expertise and in which we believe we can grow 10
  • 12. Ensure sustainable profitability Italy (1/2) GWP breakdown: Evolution 2009-2011 In EUR mio CAGR 2009-2011: +1,3% 210 mio 213 mio 15,5 % 10% 10,5% 216 mio 11% 35,5% 43,5% Motor 38% 11% 30,5% 2009 36% Accident & Health 39% 36% 2010  Strong performance in CPI Core and Non-Motor Others Fire 14% 11,5%  Focus on profitable growth (product mix switch to more profitable LoB) 2011 Auto excluded South 2012 net production in # 439 2012 312 123 (129) Jan (376) Feb (376) (322) (78) Mar Apr (429) 203 2011 (99) May Jun  Better segmentation in Motor  Reduction of Loss ratio on Motor business (Over 3 points improvement as lack of big claims in H1 2012) (638) Investor Day 24&25 September 2012 - Andaz Liverpool Street London 11
  • 13. Ensure sustainable profitability Italy (2/2)  Actions taken in 2011 to improve business Health 2012 total net production in # and redress profitability (a.o. banc assurance product offer simplification)  Portfolio being pruned, now set for growth:  New products to increase non-Motor contribution (BluFamily, new CPI, new Household policies)  Operations optimization: − Claims management (rationalization of claims settlement center) − Implementation of a successful Fraud Prevention Program (Black box) 1501 2012 1377 913 838 933 455 2011 830 479 Jan 393 352 Feb Mar Apr 476 290 May Jun  Introduction of a new Health product, Blu Family, launched in Jan. 2012 and leading to increased sales in Health Investor Day 24&25 September 2012 - Andaz Liverpool Street London 12
  • 14. Leverage growth potential & enhance profitability Turkey (1/2)  Phase 1 “Quick wins” realized in 2011 (a.o. Evolution of GWP per business line (Ytd) In TRY mio financials improved via active management of the investment portfolio, workshops on Knowledge Sharing) 706 607 15% 16% 9% 8% 11% 8% Health Gen. losses Other 47% 2% 14% 6M 11 Motor 2% 17% 51% Marine Fire  Now: Phase 2 “Improving business case”:  Strategic shift towards non-Motor  Agency channel profit and effectiveness 6M 12 optimization Focus on profitable growth – Market GWP Analysis June 2012 Aksigorta Market  Underwriting / Pricing / Reserves Methodologies  Claims process reengineering (Claim Management, Fraud prevention, IT systems, …) Top 10 55%  Bancassurance 45% 43% 38% 31% 18% 19% 16% 13% 10% 21% 15% 15% 14% 22% 23% 22% 22% 65% 59% 8% 3% 2% Total GWP Fire Marine Motor Other General losses Health Investor Day 24&25 September 2012 - Andaz Liverpool Street London 13
  • 15. Leverage growth potential & enhance profitability Turkey (2/2) Evolution of GWP per distribution channel (Ytd) In % Direct sales (13%) 108 Brokers (9%) Banks (13%) Evolution of combined ratio EUR 275 mio Agencies (65%) 107 Market (Non-Life) 106.5 106 101.6 6M 11 99 Direct sales (11%) Aksigorta Brokers (13%) EUR 302 mio Agencies (59%) 2009 Banks (14%) 2010 2011 6M 12 Investor Day 24&25 September 2012 - Andaz Liverpool Street London 14
  • 16. Conclusion: Robust Performance of Ageas Continental Europe Non-Life activities Combined ratio CEU** 2009 – 6M 12 Non-Life – evolution of GWP In EUR mio 537 Other 83 101.3% Fire 87 CAGR: +61% * 27.6% 62.4% 27 81 Accident & Health 29.2% 29.3% 25.4% 27.5% 71.0% 66.4% 70.1% 67.3% 64.9% 61.0% 2010 2011 3M 11 6M 11 3M 12 6M 12 170 2009 6M 09 30.3% 88.5% 197 128 10 12 96.6% 90.3% 30.3% Motor 99.3% 96.7% 90.0% 6M 12 * integration Turkey as of end 2011 claims ratio expense ratio ** excluding Turkey  Blueprint set up and ready for deployment Vision 2015  Pool of people with technical skills available for execution Investor Day 24&25 September 2012 - Andaz Liverpool Street London 15
  • 17. Disclaimer Certain of the statements contained herein are statements of future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Future actual results, performance or events may differ materially from those in such statements due to, without limitation, (i) general economic conditions, including in particular economic conditions in Ageas’s core markets, (ii) performance of financial markets, (iii) the frequency and severity of insured loss events, (iv) mortality and morbidity levels and trends, (v) persistency levels, (vi) interest rate levels, (vii) currency exchange rates, (viii) increasing levels of competition, (ix) changes in laws and regulations, including monetary convergence and the Economic and Monetary Union, (x) changes in the policies of central banks and/or foreign governments and (xi) general competitive factors, in each case on a global, regional and/or national basis. In addition, the financial information contained in this presentation, including the pro forma information contained herein, is unaudited and is provided for illustrative purposes only. It does not purport to be indicative of what the actual results of operations or financial condition of Ageas and its subsidiaries would have been had these events occurred or transactions been consummated on or as of the dates indicated, nor does it purport to be indicative of the results of operations or financial condition that may be achieved in the future. Investor Day 24&25 September 2012 - Andaz Liverpool Street London 16